Cite
Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease
MLA
Hefeng, Zhou, et al. “Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson’s Disease.” Oxidative Medicine and Cellular Longevity, vol. 2019, Mar. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e470de9343eeb3320b4d352573e1bfab&authtype=sso&custid=ns315887.
APA
Hefeng, Z., Min, S., Xuanjun, Y., Chuwen, L., Guozhen, C., Cheng, G., Lijun, D., Hanbing, Z., Yuqiang, W., Zaijun, Z., & Simon Ming-Yuen, L. (2019). Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson’s Disease. Oxidative Medicine and Cellular Longevity, 2019.
Chicago
Hefeng, Zhou, Shao Min, Yang Xuanjun, Li Chuwen, Cui Guozhen, Gao Cheng, Di Lijun, et al. 2019. “Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson’s Disease.” Oxidative Medicine and Cellular Longevity 2019 (March). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........e470de9343eeb3320b4d352573e1bfab&authtype=sso&custid=ns315887.